Exploring the oral manifestations of Hepatitis C in children and their diagnostic significance for early liver disease detection.
An in-depth analysis of COVID-19's third wave, examining virological evolution, clinical outcomes, and global responses to the pandemic's resurgence.
Exploring how daclatasvir-based regimens are revolutionizing Hepatitis C treatment with cure rates exceeding 95% and their role in global elimination efforts.
How glecaprevir/pibrentasvir (G/P) is revolutionizing Hepatitis C treatment for underserved populations with 98% cure rates across all patient groups.
Exploring how viral DNA integration shapes human biology, from evolution to disease, with 8% of our genome containing viral remnants.
Exploring the connection between herpes simplex viruses and oral squamous cell carcinoma, with focus on Sudanese studies revealing HSV-2's unexpected role.
Breakthrough research on using sofosbuvir/velpatasvir (SOF/VEL) to treat Hepatitis C in pregnant women and prevent mother-to-child transmission.
Exploring the hidden threat of ALT flares in asymptomatic hepatitis C carriers and the global impact of chronic liver diseases.
Exploring the critical field of paediatric virology, its medical terminology, and recent breakthroughs in treating viral infections in children.
Exploring how IL28B gene variants and liver enzyme profiles predict HCV treatment outcomes in Egypt's unique genotype 4 population.